Popular on EntSun
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 295
- Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick - 243
- "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society - 202
- Donna Cardellino Manager/Facilitator Signs Justin Jeansonne Country Singer-Songwriter To Exclusive Management Deal For Global Music Expansion - 150
- VDG Virtuoso Emerges as a New-Model Independent Industry Figure Blending Artist, Executive, and Infrastructure Builder - 143
- Oliver Sean's "Everyday Will Be Like A Holiday" Featuring the Real Indie Project Hits #1 in Portugal on Christmas Eve - 120
- UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote - 119
- Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence - 112
- Kaltra Launches Next-Gen MCHEdesign With Full Integration Into MCHEselect — Instant Simulation & Seamless Microchannel Coil Workflow - 111
- AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue - 110
Similar on EntSun
- High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
- CCHR Says Mounting Evidence of Persistent Sexual Dysfunction From Antidepressants Demands FDA Action
- Acmeware and Avo Partner to Bring Real-Time Data Integration to MEDITECH Customers
- New Analysis Reveals Most Patients Discontinue Weight Loss Drugs Within First Year
- Preston Dermatology & Skin Surgery Center Wins Gold and Bronze in Prestigious Annual DIAMOND Awards
- The Stork Foundation Announces 2025 Year-End Impact and Grant Awards Amid Rising National Demand
- Japan's Patented "Hammock'n" Smartphone Band Targets Hand Fatigue From Long Phone Use
- CCHR: Harvard Review Exposes Institutional Corruption in Global Mental Health
- Global License Exclusive Secured for Emesyl OTC Nausea Relief, Expanding Multi-Product Growth Strategy for Caring Brands, Inc. (N A S D A Q: CABR)
- American Laser Study Club Announces 2026 Kumar Patel Prize in Laser Surgery Recipients: Ann Bynum, DDS, and Boaz Man, DVM
Filos Health Laboratory to Attend JPMorgan Healthcare Week 2026
EntSun News/11081930
Advancing Precision Diagnostics and AI-Driven Clinical Intelligence for the Future of Healthcare
DALLAS - EntSun -- Filos Health Laboratory and Filos Health Mobile Blood Collection, a CLIA- and COLA-accredited clinical diagnostics and mobile blood company specializing in precision laboratory testing and AI-powered clinical intelligence, announced today that it will attend JPMorgan Healthcare Week 2026 in San Francisco.
During JPM Health Week, Filos Health will engage with healthcare investors, health system leaders, biopharma partners, and innovators to discuss its mission to transform clinical diagnostics by moving beyond static lab results toward predictive, longitudinal insights that improve patient outcomes.
Filos Health integrates high-quality clinical laboratory testing with advanced artificial intelligence to analyze longitudinal lab data and predict clinical outcomes at 6-month and 12-month horizons. The company currently serves tens of thousands of patients annually across Texas and California, supporting physicians, health systems, and enterprise partners with scalable diagnostic and mobile phlebotomy solutions.
More on EntSun News
"Healthcare generates vast amounts of laboratory data, yet most of it remains underutilized," said Nida Fatima, MD, Founder and CEO of Filos Health Laboratory. "At Filos Health, we believe lab data should not just report the past—it should help predict the future. JPM Healthcare Week provides an important forum to share how we are building the clinical operating system for human biology."
Filos Health is actively engaging with strategic partners and investors aligned with its vision to modernize clinical diagnostics, improve care delivery, and enable data-driven precision medicine at scale.
About Filos Health Laboratory
Filos Health Laboratory is a women-owned, CLIA- and COLA-accredited clinical diagnostics company delivering precision laboratory testing, mobile phlebotomy services, and AI-powered clinical intelligence. Founded in 2018, the company serves patients and providers across Texas and California, with a mission to turn laboratory data into actionable insights that improve health outcomes.
Learn more about clinical diagnostic company: https://www.filoshealthlab.ocm
Learn more about mobile blood collection: https://www.filoshealth.com
During JPM Health Week, Filos Health will engage with healthcare investors, health system leaders, biopharma partners, and innovators to discuss its mission to transform clinical diagnostics by moving beyond static lab results toward predictive, longitudinal insights that improve patient outcomes.
Filos Health integrates high-quality clinical laboratory testing with advanced artificial intelligence to analyze longitudinal lab data and predict clinical outcomes at 6-month and 12-month horizons. The company currently serves tens of thousands of patients annually across Texas and California, supporting physicians, health systems, and enterprise partners with scalable diagnostic and mobile phlebotomy solutions.
More on EntSun News
- UK Financial Ltd Makes History as MayaCat (SMCAT) Becomes the World's First Exchange-Traded ERC-3643 Security Token
- Narcissist Apocalypse Marks 7 Years as a Leading Narcissistic Abuse Podcast
- High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
- CryptaBox Introduces a Hardware Crypto Cold Storage Wallet
- YWWSDC Launches AI-Native Digital Asset Infrastructure, Merging Technical Innovation with US-Standard Compliance
"Healthcare generates vast amounts of laboratory data, yet most of it remains underutilized," said Nida Fatima, MD, Founder and CEO of Filos Health Laboratory. "At Filos Health, we believe lab data should not just report the past—it should help predict the future. JPM Healthcare Week provides an important forum to share how we are building the clinical operating system for human biology."
Filos Health is actively engaging with strategic partners and investors aligned with its vision to modernize clinical diagnostics, improve care delivery, and enable data-driven precision medicine at scale.
About Filos Health Laboratory
Filos Health Laboratory is a women-owned, CLIA- and COLA-accredited clinical diagnostics company delivering precision laboratory testing, mobile phlebotomy services, and AI-powered clinical intelligence. Founded in 2018, the company serves patients and providers across Texas and California, with a mission to turn laboratory data into actionable insights that improve health outcomes.
Learn more about clinical diagnostic company: https://www.filoshealthlab.ocm
Learn more about mobile blood collection: https://www.filoshealth.com
Source: Filos Health Laboratory
Filed Under: Health
0 Comments
Latest on EntSun News
- Simpson and Reed Co-Founders Shardé Simpson, Esq. and Ciara Reed, Esq. Launch "Hello Wilma,"
- Report Outlines Key Questions for Individuals Exploring Anxiety Treatment Options in Toronto
- Rande Vick Introduces Radical Value, Challenging How Brands Measure Long-Term Value
- Lisa Mauretti Launches Peace of Mind Travel Coaching to Guide Fearful Travelers to Discover the World with Confidence
- New Year, New Home: Begin 2026 at Heritage at South Brunswick
- Higginswerx Honored as Winner in FlovaAI Christmas Creator Challenge
- Food Journal Magazine Releases Its 'Best Food In Los Angeles Dining' Editorial Section
- Enders Capital: 25% Gains with Just -0.80% Maximum Monthly Drawdown in Volatile Debut Year 2025
- Max Weinberg Brings His Max Weinberg's Jukebox to the Weinberg Center
- Venture Beyond the Ordinary in "AJ AND THE INCREDIBLE FISH" by Paolo Mazzucato
- CES Spotlight Highlights Need for Strategic Review as Throughput Demands Evolve
- ASR Media, Social T Marketing & PR Announce Merger
- $780,000 Project for New Middle East Police Service with Deposit Received and Preliminary Design Work Underway for Lamperd: Stock Symbol: LLLI
- The 3rd Annual Newark Summit for Real Estate, Economic Development & Placemaking Returns February 9th
- Cygnet Theatre Announces The Cast And Creative Team Of Somewhere Over The Border
- Ski Safety Awareness Month highlights why seeing clearly and wearing modern protection matters more than ever
- Vent Pros Expands Operations into Arizona to Meet Growing Demand for Commercial Ventilation and Kitchen Hood Cleaning Services
- Spirit of Creativity Celebrated with Gold for Destination: Scientology, Amsterdam at Viddy Awards
- Klein Civil Rights Expands with New Offices in New York's Historic Woolworth Building
- Biz Hub Financial Hosts 9th Annual Client Appreciation Event, Awards $1,000 CARES Community Grant